Jump Financial’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-43,325
Closed -$597K 2079
2026
Q1
$597K Buy
+43,325
New +$653K 0.01% 1151
2025
Q3
Sell
-535,059
Closed -$8.56M 1850
2025
Q2
$8.56M Buy
535,059
+328,094
+159% +$5.85M 0.09% 278
2025
Q1
$4.02M Buy
206,965
+65,965
+47% +$1.39M 0.05% 384
2024
Q4
$3.11M Buy
141,000
+11,609
+9% +$223K 0.06% 384
2024
Q3
$2.18M Sell
129,391
-76,895
-37% -$1.14M 0.04% 483
2024
Q2
$2.47M Buy
206,286
+63,030
+44% +$704K 0.05% 470
2024
Q1
$1.59M Buy
143,256
+80,839
+130% +$825K 0.04% 557
2023
Q4
$541K Sell
62,417
-5,383
-8% -$41.8K 0.02% 1014
2023
Q3
$519K Buy
67,800
+29,900
+79% +$224K 0.02% 997
2023
Q2
$273K Buy
+37,900
New +$221K 0.01% 1357

Other funds holding CLBT

Jump Financial's CLBT Position: Q2 2026 in Review

Jump Financial sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 43,325 shares — an estimated $597K sold.

Jump Financial first reported a position in CLBT in Q2 2023 and held it in 10 quarters. The position peaked at $8.56M in Q2 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jump Financial reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 43,325 Cellebrite shares in Q2 2026, an estimated $597K.
  • Jump Financial first reported a position in Cellebrite in Q2 2023 and held it in 10 quarters.
  • Jump Financial's Cellebrite position peaked at $8.56M in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.